This hypothesis is further supported by our findings here that Paqr8 is spontaneously upregulated and frequently undergoes CN gain in recurrent mammary tumors in mice arising from Her2, Akt, Myc, and Wnt1-induced primary tumors subjected to oncogene downregulation, which is a genetic surrogate for targeted therapy. This evidence concerns the gene ERBB2 and breast cancer.